160 related articles for article (PubMed ID: 32017004)
1. MiRNA-215-5p alleviates the metastasis of prostate cancer by targeting PGK1.
Chen JY; Xu LF; Hu HL; Wen YQ; Chen D; Liu WH
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):639-646. PubMed ID: 32017004
[TBL] [Abstract][Full Text] [Related]
2. miR-138-5p inhibits the malignant progression of prostate cancer by targeting FOXC1.
Zhang D; Liu X; Zhang Q; Chen X
Cancer Cell Int; 2020; 20():297. PubMed ID: 32669973
[TBL] [Abstract][Full Text] [Related]
3. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
4. MiR-219-5p inhibits prostate cancer cell growth and metastasis by targeting HMGA2.
Huang WT; Zhang H; Jin Z; Li K; Hu C; Li ML; Situ J
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4710-4718. PubMed ID: 32432734
[TBL] [Abstract][Full Text] [Related]
5. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
6. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
7. Circ_0076305 facilitates prostate cancer development via sponging miR-411-5p and regulating PGK1.
Ding X; Sun J; Zhang X
Andrologia; 2022 Jul; 54(6):e14406. PubMed ID: 35238066
[TBL] [Abstract][Full Text] [Related]
8. Biological functions of miRNA-188-5p/XRCC5 in the metastasis of glioma.
Leng N; Zhou W; Jiang L; Zhao Y; Zhou M; Sun S; Nie W
J BUON; 2021; 26(2):359-365. PubMed ID: 34076980
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-203a-5p alleviates the malignant progression of Wilms' tumor via targeting JAG1.
Bao JW; Li WJ; Guo JH; Lv ZB; Whang Z
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5329-5335. PubMed ID: 32495866
[TBL] [Abstract][Full Text] [Related]
10. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.
Niu XY; Zhang ZQ; Ma PL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6983-6990. PubMed ID: 31486498
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
12. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
[TBL] [Abstract][Full Text] [Related]
13. LncSNHG16 promotes proliferation and migration of osteosarcoma cells by targeting microRNA-146a-5p.
Zheng SN; Ge DW; Tang J; Yang J; Yan JW; Qiu JJ; Yin ZW; Ni Y; Zhao L; Chen X; Yang L
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):96-104. PubMed ID: 30657551
[TBL] [Abstract][Full Text] [Related]
14. MiR-605-3p inhibits malignant progression of prostate cancer by up-regulating EZH2.
Pan MZ; Song YL; Gao F
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8795-8805. PubMed ID: 31696466
[TBL] [Abstract][Full Text] [Related]
15. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
16. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
Tong WH; Mu JF; Zhang SP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6639-6646. PubMed ID: 32633353
[TBL] [Abstract][Full Text] [Related]
17. MiRNA-188-5p alleviates the progression of osteosarcoma via target degrading CCNT2.
Wang F; Zhao QH; Liu JZ; Kong DL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):29-35. PubMed ID: 31957815
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335.
Wang WJ; Sun K; Li FY; Hui XB; Liu D; Liu J; Wang XD
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):758-765. PubMed ID: 32016979
[TBL] [Abstract][Full Text] [Related]
19. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis.
Jiang S; Chen H; He K; Wang J
Bioengineered; 2022 Feb; 13(2):2004-2016. PubMed ID: 35030978
[TBL] [Abstract][Full Text] [Related]
20. MiRNA-146b-5p inhibits the malignant progression of gastric cancer by targeting TRAF6.
Ding JN; Zang YF; Ding YL
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8837-8844. PubMed ID: 32964972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
